Antidepressants are widely prescribed for depression, anxiety, and other mental health conditions, and are generally considered safe for pregnant women. However, recent studies have raised concerns about potential links between prenatal antidepressant exposure and neurodevelopmental disorders such as attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in children.
What the Research Shows
A growing body of evidence suggests that taking antidepressants during pregnancy may slightly increase the risk of ADHD and autism in offspring. A 2025 meta-analysis published in JAMA Psychiatry found that children exposed to antidepressants in utero had a 20% higher likelihood of developing ADHD and a 15% higher risk of autism compared to unexposed children. However, the absolute risk remains low, and the studies cannot fully rule out confounding factors such as the severity of maternal depression.
Balancing Benefits and Risks
Untreated maternal depression itself poses significant risks to both mother and baby, including preterm birth, low birth weight, and postpartum depression. Dr. Emily Hart, a perinatal psychiatrist at Toronto General Hospital, emphasizes: “The decision to use antidepressants during pregnancy must be individualized. For many women, the benefits of treating depression outweigh the potential small risks to the child.”
Expert Recommendations
- Consult your healthcare provider before making any changes to medication during pregnancy.
- Consider non-pharmacological treatments such as cognitive behavioral therapy (CBT) as a first-line option for mild to moderate depression.
- Monitor for side effects in both mother and baby after birth.
Types of Antidepressants and Risks
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants during pregnancy. Studies have shown that paroxetine (Paxil) may carry a slightly higher risk of congenital heart defects, while other SSRIs like sertraline (Zoloft) and fluoxetine (Prozac) are considered safer alternatives. Bupropion (Wellbutrin) has been linked to a small increase in ADHD risk.
What Parents-to-Be Should Know
The decision to take antidepressants during pregnancy is complex. A shared decision-making approach involving the patient, obstetrician, and mental health professional is crucial. “Pregnant women should not abruptly stop their medication without medical supervision, as withdrawal symptoms and relapse of depression can be severe,” warns Dr. Hart.
Further research is needed to clarify the mechanisms behind the observed associations and to identify which patients are most at risk. In the meantime, healthcare providers recommend close monitoring and individualized treatment plans.
